Perth-based burns treatment developer Clinical Cell Culture Ltd, or C3, announced it will close its American offices and sell its CellSpray technology after completing a strategic review of its options.

Perth-based burns treatment developer Clinical Cell Culture Ltd, or C3, announced it will close its American offices and sell its CellSpray technology after completing a strategic review of its options.